Loading
Doctors rarely take a full family history, so eligibility for genetic testing goes undetected. An app that gathers the history from the patient, feeds it into the record and checks it against NCCN or NICE criteria would identify several-fold more eligible people and, the proposal estimates, roughly double the number tested.
Doctors rarely take a full family history, so this idea integrates patient-entered family history into the EHR at every new-patient visit, auto-matches it to NCCN or NICE testing criteria and triggers automatic referral or mainstream testing. Tools such as MeTree and CanRisk exist but are not part of routine care, and eligibility is common but rarely detected. The aim is several-fold more guideline-eligible individuals identified and roughly twice as many tested. The test is a cluster RCT in primary care networks. At early-clinical maturity it addresses the bottleneck Inherited risk is mostly unidentified and links to germline testing.
Shares National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer, Inherited risk is mostly unidentified, Germline (hereditary) testing.
Shares National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer, Inherited risk is mostly unidentified, Germline (hereditary) testing.
Shares National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer, Inherited risk is mostly unidentified, Germline (hereditary) testing.
Shares National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer, Inherited risk is mostly unidentified, Germline (hereditary) testing.
Shares National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer, Inherited risk is mostly unidentified, Germline (hereditary) testing.
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing.
Shares National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer, Inherited risk is mostly unidentified.
Shares National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer, Inherited risk is mostly unidentified, Germline (hereditary) testing.